Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-10
2005-05-10
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S345000, C514S354000, C546S001000, C546S290000, C546S314000
Reexamination Certificate
active
06890932
ABSTRACT:
The present invention relates to an anthranilic acid derivative expressed by the following formula (1) or the following formula (2), or its pharmacologically permissible salt or solvate.
REFERENCES:
patent: 0 763523 (1997-03-01), None
patent: 1-287066 (1989-11-01), None
patent: 1-106818 (1990-04-01), None
patent: 5-9170 (1993-01-01), None
patent: 733743 (1995-02-01), None
patent: 7-97350 (1995-04-01), None
patent: 7-285858 (1995-10-01), None
patent: 9012001 (1990-10-01), None
patent: 9525723 (1995-09-01), None
patent: 9532943 (1995-12-01), None
patent: 9719910 (1997-06-01), None
M. Hasegawa, et al., Journal of Medicinal Chemistry, 1997, vol. 40, No. 4, 395-407, “Novel Naphthalene Derivatives as Inhibitors of Human Immunoglobulin E Antibody Production.”
Hase Naoki
Takeuchi Susumu
Takeyasu Takumi
Tsuchiya Naoki
Tsuruo Takashi
Pryor Alton
Teijin Limited
LandOfFree
Anthranilic acid derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthranilic acid derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthranilic acid derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3454384